Back

Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy

25 August 2018 (11:52 - 12:05)
Organised by:
Congress Presentation Part of: Cardiac phenotyping and outcome implications Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Niccolo' Maurizi

University Hospital of Lausanne, Lausanne (Switzerland)

6 More presentations in this session

Presentation thumbnail
Short-term adverse remodelling in asymptomatic aortic stenosis: a longitudinal cardiovascular magnetic resonance imaging study
Doctor A. Singh (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Insulin resistance, left ventricular hypertrophy and the impact of metformin use on cardiovascular outcomes in patients with calcific aortic stenosis: a genetic and population cohort study
Doctor I. Mordi (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
Prognostic value of cardiac damage in patients with symptomatic severe aortic stenosis: implementation of a newly proposed staging classification
Mrs E. Vollema (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Trends in prevented sudden death in cardiomyopathies and channelopathies
Doctor J. Gimeno Blanes (Murcia, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic value of progressive decrease in left ventricular wall thickness for the evaluation of sudden cardiac death risk in patients with hypertrophic cardiomyopathy.
Doctor A. Quiroga (Buenos Aires, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac phenotyping and outcome implications

The Event

Event poster

ESC Congress 2018

25 August 2018 11:52 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources